Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BT001 phase Ib/II study in adult upper limb spasticity
CTR20253608Phase 2Active
- Sponsor
- Beijing Botewike Biotechnology
- Start
- Sep 2025
- Modality
- Oncolytic Viruses → Oncolytic Therapeutics, Gene Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of BT-001 in upper extremity spasticity, sponsored by Beijing Botewike Biotechnology. Started Sep 2025; status: active.
02
Drugs
BT-001
03
Conditions
upper extremity spasticity
Beyond the preview
Go deeper on CTR20253608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253608.